- Top Biopharma Brands Reach Audiences 10x More Qualified with Veeva Crossix Prime Segments
- Veeva Launches AI Partner Program
- Veeva Announces Vault CRM Campaign Manager
- Biopharma Leaders Come Together at Veeva Commercial Summit to Advance Customer-Centric Engagement
- Veeva Vault CRM Now Available for All New Customers
- Veeva Vault EDC Surpasses 1,000 Study Start Milestone
- Veeva Announces Fourth Quarter and Fiscal Year 2024 Results
- Dr. Pfleger Arzneimittel Scales Digital Field Engagement with Veeva Commercial Cloud
- Boehringer Ingelheim Partners with Veeva to Advance its Clinical and Regulatory Operations in Animal Health
- New Veeva Vault Submissions Publishing eLearning Application Speeds Employee Onboarding
More ▼
Key statistics
As of last trade Veeva Systems Inc (VEEV:NYQ) traded at 201.27, -15.04% below its 52-week high of 236.90, set on Mar 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 200.51 |
---|---|
High | 202.10 |
Low | 199.71 |
Bid | 200.91 |
Offer | 201.29 |
Previous close | 199.09 |
Average volume | 917.74k |
---|---|
Shares outstanding | 161.32m |
Free float | 146.85m |
P/E (TTM) | 58.39 |
Market cap | 32.12bn USD |
EPS (TTM) | 3.41 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 15:55 BST.
More ▼